FdaApplication
BLA 761315
Identifiers
- fda_app_no: BLA761315
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2024-12-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALHEMO | CONCIZUMAB-MTCI | 60MG/1.5ML (40MG/ML) | Injectable;Subcutaneous |
| ALHEMO | CONCIZUMAB-MTCI | 300MG/3ML (100MG/ML) | Injectable;Subcutaneous |
| ALHEMO | CONCIZUMAB-MTCI | 150MG/1.5ML (100MG/ML) | Injectable;Subcutaneous |
3 products